Topic: Obesity/ Excess Adiposity EIT
Objectives:
Review the incidence of obesity in New Zealand and understand how these stats are derived
Understand the factors that influence obesity
Explain the pathophysiology of obesity
Understand the complications of obesity and the implications for health and disease
Identify assessments used to monitor and manage obesity
Date: 14 February 2024
Definition of Obesity:
Overweight and obesity are defined as abnormal or excessive fat accumulation that presents a risk to health.
A body mass index (BMI) over 25 is considered overweight, and over 30 is obese.
Most population obesity statistics are reported using BMI (body mass index, kg/m2)
Date: 14 February 2024
Limitations of BMI:
BMI is not a direct measure of body fatness because it is a measure of excess weight rather than excess body fat
Factors such as age, sex, ethnicity, and muscle mass can influence the relationship between BMI and body fat
It is more useful as a population level statistics rather than an individual measure
Date: 14 February 2024
New Zealand Obesity Statistics:
Depending on the data, NZ has the third or fourth highest obesity rates in the world
1 in 3 NZ adults (15 and over) are classified as obese
Prevalence by ethnicity:
Pacifica 71.3%
Maori 50.8%
European/other 31.9%
Asian 18.5%
12.7% of NZ children
Date: 14 February 2024
Source: New Zealand Health Survey 2020/21
Should we consider using other terms rather than obesity?
The term "obese" has several negative connotations
Research suggests using terms such as "weight," "BMI," "weight problem," or "excess weight" are preferred by patients
Date: 14 February 2024
Factors that influence obesity:
TASTE
Food preferences
Time convenience
Allergy/intolerance
Accessibility
Knowledge
Habit
Cost
Social and cultural aspects
Macros
Satiety
Fiber
Genetics
Age
Stress
Hormones
Gender
Enjoyment
Safety
Affordability
Motivation
Physical ability
Time
Habit
Post-exercise activity
NEAT
Resistance/cardio
Macro interactions
FOOD
EXERCISE
Date: 14 February 2024
Risk factors for obesity:
There is no single cause – there are many factors that impact the development of obesity
Unhealthy diet
Physical inactivity
Stress
Smoking
Socioeconomic factors
Genetic factors (at least 8 genes)
Metabolic disorders
Hormone imbalances
Date: 14 February 2024
Concerns about obesity:
Obesity significantly raises the risk of serious health conditions such as diabetes, cardiovascular problems, dementia, some cancers, mental illnesses, and chronic pain
Date: 14 February 2024
Source: Ministry of Health. 2015. Understanding Excess Body Weight: N Wellington: Ministry of Health.
Adipose cells are metabolically active:
Produce hormones and cytokines that regulate food intake, lipid storage, metabolism, insulin sensitivity, and female reproduction
Influence the immune system, vascular homeostasis, and BP
Stimulate angiogenesis
Date: 14 February 2024
Food intake- appetite:
HORMONES
Stomach
Adipose tissue
Taste
Cerebral cortex
Smell
Ghrelin
Leptin
Sight
Increases appetite
Decreases appetite
Emotions
Stimulates
Inhibits
Hypothalamus
Nutrients
GI hormones
Insulin
Neural signals
Adipose
GI tract
Food intake
Energy
Energy absorbed
Ingested
Date: 14 February 2024
Source: Guyton AC, Hall JE. Textbook of medical physiology. 10th edn. Philadelphia: Saunders; 2000.
Control of appetite:
Normal body weight
Obesity
Normal fat cell mass
Increase in fat cell mass means that Leptin level normal
Leptin level increased excessively affecting the Hypothalamus
Resulting in Decreased appetite and food intake
Leptin resistance and other hormone Increased metabolism action
Increased sympathetic activity
Increased appetite and food intake
Decreased metabolism
Sustained sympathetic activity
Date: 14 February 2024
Source: Guyton AC, Hall JE. Textbook of medical physiology. 10th edn. Philadelphia: Saunders; 2000.
The link between obesity and health:
Hypertrophic adipocytes
Normal adipocytes
Impaired lipid metabolism
Excess energy intake
Altered adipokine secretion
Immune cell infiltration
Inflammation
Insulin resistance
Preadipocyte recruitment
Preadipocytes
White adipose tissue
Lipid accumulation
Pre-Adipocyte
Liver
Inflammation
ROS
Insulin resistance
Lipid spill-over
Adipocyte
Systemic inflammation
ROS
Muscle
Lipid accumulation
Adipocyte
Insulin resistance dysfunction
ROS, Cytokines
MetS, T2D
Date: 14 February 2024
Obesity & chronic inflammation:
Excess adiposity results in increased production of free fatty acids (FFA) and pro-inflammatory cytokines
Excessive production of pro-inflammatory cytokines contributes to inflammatory disease
Chronic inflammation has been linked to many chronic diseases, including atherosclerosis, cancer, and depression
Date: 14 February 2024
Obesity & insulin resistance:
Free fatty acids (FFA) are an essential fuel source (From Triglycerides = blood test)
Enlarged adipocytes release more FFAs than normal adipocytes
As FFA concentrations increase, insulin's antilipolytic action is inhibited = more FFA
High FFA = decrease glucose uptake in muscle
Muscle tissue – including cardiac become insulin resistant
This is insulin resistance
Date: 14 February 2024
Health complications of obesity:
Insulin resistance
Insulin resistance: tissues unresponsive to insulin especially muscle, liver, fat cells
Impaired glucose tolerance
Hyperglycemia
Dyslipidemias: triglycerides, LDL cholesterol, ↓ HDL cholesterol
Metabolic syndrome – pre-diabetes
Date: 14 February 2024
Health complications of obesity:
Type 2 Diabetes
Higher risk factor for those with central obesity
Gallbladder and liver disease
3-4 fold increased risk of gallstones
Steatohepatitis
Mortality
12-fold greater mortality in the 25-35 age group
Date: 14 February 2024
Health complications of obesity:
Cardiovascular disease
Dyslipidemia
Abnormalities of coagulation
Increased risk of thrombus formation
Atherosclerosis
Respiratory disorders
Obesity impairs respiratory function
High incidence of obstructive sleep apnea
Osteoarthritis
Date: 14 February 2024
Assessment of Obesity:
Health history
Physical examination
Blood analysis of:
Cholesterol- LDL, HDL & Triglycerides
C-reactive protein
HbA1c
Full Blood Count
Liver Function Test
Date: 14 February 2024
Evaluation of body size:
Body mass index (BMI)
BMI = weight (kg) ÷ height (m2)
Waist circumference
Central obesity versus
Body mass index (BMI) classification:
Underweight: BMI < 18.50
Severe thinness: BMI < 16.00
Moderate thinness: BMI 16.00 - 16.99
Mild thinness: BMI 17.00 - 18.49
Normal range: BMI 18.50 - 24.99
Overweight: BMI > 25.00
Pre-obese: BMI 25.00 - 29.99
Obese: BMI > 30.00
Obese class I: BMI 30.00 - 34.99
Obese class II: BMI 35.00 - 39.99
Obese class III: BMI > 40.00
Additional cut-off points for thinness and normal range categories
Body builder and sedentary categories
Body mass index (BMI) and basal metabolic rate (BMR) values
Waist circumference and its relation to disease risk
Abdominal obesity and its impact on metabolic disease risk
Bioelectrical impedance analysis as a method to calculate fat and fat-free mass
Advantages of bioelectrical impedance analysis
Ability to determine fat distribution in some versions
DXA scans for body composition analysis
Health at any size approach
Avoid assuming that overweight or obese individuals are automatically unhealthy
Consider ethnicity, culture, and lifestyle factors when providing advice
Never assume lack of education as the reason for someone's diet or lifestyle choices
Management of obesity
Aim is prevention of obesity-related diseases
Non-pharmacological lifestyle changes: healthy diet, regular exercise, sleep and relaxation, green prescription/lifestyle programs
Emphasis on improving activity levels for overall health improvement
Pharmacological/supplement options
Bariatric surgery
Childhood obesity statistics in New Zealand
Risk factors for childhood obesity
Higher prevalence in children from low socioeconomic status and obese parents
Psychological factors, sedentary lifestyle, and high-calorie diet as risk factors
Complications of childhood obesity
Social and psychological issues
Changes in bone shape
Acanthosis nigricans
Altered onset of puberty
Gynecomastia in boys
Metabolic complications: dyslipidemia, hypertension, type 2 diabetes, gallstones, osteoarthritis, and obstructive sleep apnea
Treatment